Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 58.1B | 63.7B | 58.2B | 45.4B |
| Cost of revenue | 40.8B | 43.4B | 42.8B | 29.8B |
| Gross profit | 17.3B | 20.3B | 15.5B | 15.6B |
| Operating expense | ||||
| Research & development | — | 224.2M | 407.8M | 255.3M |
| Selling general and admin | 6.6B | 6.3B | 6.3B | 3.7B |
| Other operating expenses | — | 275.7M | 647.5M | 1.7B |
| Operating income | 17.3B | 10.7B | 3.9B | 6.9B |
| Non operating interest income | ||||
| Income | — | 790.3M | 1.0B | 1.1B |
| Expense | — | 15.9M | 17.0M | 16.9M |
| Other income expense | — | — | — | — |
| Pretax income | 8.3B | 11.5B | 9.2B | 5.8B |
| Tax provision | 1.9B | 2.3B | 1.7B | 1.7B |
| Net income | 6.5B | 9.2B | 7.5B | 4.1B |
| Basic EPS | 243.1 | 346 | — | 151 |
| Diluted EPS | 243.1 | 346 | — | 151 |
| Basic average shares | — | 26.6M | — | 27.4M |
| Diluted average shares | — | 26.6M | — | 27.4M |
| EBITDA | 17.3B | 12.5B | 10.3B | 6.8B |
| Net income from continuing op. | — | 9.2B | 7.5B | 4.1B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |